HuGE Literature Finder
|
||
Records 1-32
|
KIR2DS1, 2DS5, 3DS1 and KIR2DL5 are associated with the risk of head and neck squamous cell carcinoma in Iranians.
Human immunology 2018 Feb . Barani Shaghik, Khademi Bijan, Ashouri Elham, Ghaderi Abb |
|
Association of the genetic diversity of killer cell immunoglobulin-like receptor genes and HLA-C ligand in Saudi women with breast cancer.
Immunogenetics 2016 Sep . Alomar Suliman Y, Alkhuriji Afrah, Trayhyrn Paul, Alhetheel Abdulkarim, Al-Jurayyan Abdullah, Mansour Lamj |
|
The effect of missing KIR ligands, activating KIR genotype and haplotype on the outcome of T-cell-replete hematopoietic stem cell transplantation from HLA-identical siblings in Thai patients.
HLA 2016 Jun 87 (6): 422-31. Khanuntong S, Kuptawintu P, Upaisilpsathaporn K, Poolchareon A, Bunworasate U, Hirankarn |
|
Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells.
Cancer research 2016 Jan . Vineretsky Karin A, Karagas Margaret R, Christensen Brock C, Kuriger-Laber Jacquelyn K, Perry Ann E, Storm Craig A, Nelson Heather |
|
Genetic associations of killer immunoglobulin like receptors and class I human leukocyte antigens on childhood acute lymphoblastic leukemia among north Indians.
Human immunology 2015 Oct . Misra Maneesh Kumar, Prakash Swayam, Moulik Nirmalya Roy, Kumar Archana, Agrawal Suraks |
|
Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2015 Sep 21 (9): 1589-96. Sobecks Ronald M, Wang Tao, Askar Medhat, Gallagher Meighan M, Haagenson Michael, Spellman Stephen, Fernandez-Vina Marcelo, Malmberg Karl-Johan, Müller Carlheinz, Battiwalla Minoo, Gajewski James, Verneris Michael R, Ringdén Olle, Marino Susana, Davies Stella, Dehn Jason, Bornhäuser Martin, Inamoto Yoshihiro, Woolfrey Ann, Shaw Peter, Pollack Marilyn, Weisdorf Daniel, Milller Jeffrey, Hurley Carolyn, Lee Stephanie J, Hsu Kathari |
|
The Relationship Between Killer Cell Immunoglobulin-Like Receptors and HLA-C Polymorphisms in Colorectal Cancer in a Saudi Population.
Genetic testing and molecular biomarkers 2015 Sep . Al Omar Suliman Y, Mansour Lamjed, Dar Javid Ahmed, Alwasel Saleh, Alkhuriji Afrah, Arafah Maha, Al Obeed Omar, Christmas Steph |
|
Comparison of the KIR3DS1/Bw4 distribution in Chinese healthy and acute myeloid leukemia individuals.
Human immunology 2015 Mar 76 (2-3): 79-82. Tao Sudan, He Yanmin, Zhang Wei, Wang Wei, He Junjun, Han Zhedong, Chen Nanying, Dong Lina, He Ji, Zhu Faming, Lv Hangj |
|
Natural killer cell killer immunoglobulin-like gene receptor polymorphisms in non-Hodgkin lymphoma: possible association with clinical course.
Leukemia & lymphoma 2015 Mar 1-6. Pamuk Gulsum Emel, Tozkir Hilmi, Uyanik Mehmet Sevki, Gurkan Hakan, Duymaz Julide, Pamuk Omer Nu |
|
KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL.
Blood 2014 Oct 124 (17): 2744-7. Oevermann Lena, Michaelis Sebastian U, Mezger Markus, Lang Peter, Toporski Jacek, Bertaina Alice, Zecca Marco, Moretta Lorenzo, Locatelli Franco, Handgretinger Rupe |
|
KIR ligand C2 is associated with increased susceptibility to childhood ALL and confers an elevated risk for late relapse.
Blood 2014 Oct 124 (14): 2248-51. Babor Florian, Manser Angela R, Fischer Johannes C, Scherenschlich Nadine, Enczmann Jürgen, Chazara Olympe, Moffett Ashley, Borkhardt Arndt, Meisel Roland, Uhrberg Mark |
|
HLA and KIR genotyping correlates with relapse after T-cell-replete haploidentical transplantation in chronic myeloid leukaemia patients.
British journal of cancer 2014 Sep 111 (6): 1080-8. Zhao X-Y, Chang Y-J, Xu L-P, Zhang X-H, Liu K-Y, Li D, Huang X |
|
Killer cell immunoglobulin-like receptors in Thai patients with leukemia and diffuse large B-cell lymphoma.
Human immunology 2014 Jul 75 (7): 673-6. Vejbaesya Sasijit, Sae-Tam Pradermchai, Khuhapinant Archrob, Srinak Duangpo |
|
Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer.
Human immunology 2014 Jun 75 (6): 508-13. Giebel Sebastian, Boratyn-Nowicka Agnieszka, Karabon Lidia, Jedynak Anna, Pamula-Pilat Jolanta, Tecza Karolina, Kula Dorota, Kowal Monika, Frydecka Irena, Grzybowska E |
|
Genetic diversity of the KIR/HLA system and outcome of patients with metastatic colorectal cancer treated with chemotherapy.
PloS one 2014 9 (1): e84940. De Re Valli, Caggiari Laura, De Zorzi Mariangela, Talamini Renato, Racanelli Vito, D' Andrea Mario, Buonadonna Angela, Zagonel Vittorina, Cecchin Erika, Innocenti Federico, Toffoli Giusep |
|
HLA-Cw polypmorphism and killer cell immunoglobulin-like receptor (KIR) gene analysis in Korean colorectal cancer patients.
International journal of surgery (London, England) 2014 12 (8): 815-20. Kim Hyung-Jin, Choi Hae-Baeg, Jang Jung-Pil, Baek In-Cheol, Choi Eun-Jeong, Park Miyoung, Kim Tai-Gyu, Oh Seong-Ta |
|
Natural Killer Cell Immunoglobulin-like Receptor (KIR) genotypes in Follicular Lymphoma patients: results of a pilot study.
Gene 2013 Aug 525 (1): 136-40. Khalaf Roy, Hoteit Rouba, Yazbek Soha, El Hajj Nady, Otrock Zaher, Khansa Sarah, Sabbagh Amira, Shammaa Dina, Mahfouz Ra |
|
Homozygosity For Killer Immunoglobin-Like Receptor Haplotype A Predicts Complete Molecular Response To Treatment With Tyrosine Kinase Inhibitors In Chronic Myeloid Leukemia Patients.
Experimental hematology 2013 Feb . La Nasa G, Caocci G, Littera R, Atzeni S, Vacca A, Mulas O, Langiu M, Greco M, Orrù S, Orrù N, Floris A, Carcassi C |
|
Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia.
Experimental hematology 2012 Nov 40 (11): 906-913.e1. Kreutzman Anna, Jaatinen Taina, Greco Dario, Vakkila Emmi, Richter Johan, Ekblom Marja, Hjorth-Hansen Henrik, Stenke Leif, Melo Teresa, Paquette Ron, Seggewiss-Bernhardt Ruth, Guerci-Bresler Agnés, Talbot Alexis, Cayuela Jean Michel, Mahon Francois-Xavier, Porkka Kimmo, Lipton Jeff, Partanen Jukka, Rousselot Philippe, Mustjoki Sa |
|
Killer cell immunoglobulin-like receptor genes in patients with breast cancer.
Medical oncology (Northwood, London, England) 2012 Jun 29 (2): 511-5. Ozturk Ozlem Goruroglu, Gun Faik Deniz, Polat Gurb |
|
KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib.
Leukemia 2012 Feb 26 (2): 296-302. Marin D, Gabriel I H, Ahmad S, Foroni L, de Lavallade H, Clark R, O'Brien S, Sergeant R, Hedgley C, Milojkovic D, Khorashad J S, Bua M, Alsuliman A, Khoder A, Stringaris K, Cooper N, Davis J, Goldman J M, Apperley J F, Rezvani |
|
[Correlation of killer immunoglobulin-like receptor gene diversity with nasopharyngeal carcinoma in Chinese southern Han population].
Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology 2011 Jun 19 (3): 798-800. Lu Liang, Jin Shi-Zheng, Wang Da-Ming, Gao Su-Qing, Deng Zi-H |
|
Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.
Human immunology 2010 Oct 71 (10): 976-81. Al Omar Suliman, Middleton Derek, Marshall Ernie, Porter Dawn, Xinarianos George, Raji Olaide, Field John K, Christmas Stephen |
|
The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.
Bone marrow transplantation 2010 Oct 45 (10): 1514-21. Wu G Q, Zhao Y M, Lai X Y, Luo Y, Tan Y M, Shi J M, Li L, Zheng W Y, Zhang J, Hu X R, Jin A Y, He J S, Xie W Z, Ye X J, Cai Z, Lin M F, Huang |
|
Killer cell immunoglobulin-like receptor gene polymorphism in lymphoproliferative diseases of granular lymphocytes in a Japanese population.
Leukemia & lymphoma 2010 Aug 51 (8): 1580-1. Obama Kosuke, Makishima Hideki, Ishida Fumihi |
|
Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.
Blood 2010 May 115 (19): 3960-5. Stern Martin, Opelz Gerhard, Döhler Bernd, Hess Christo |
|
Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.
Human immunology 2010 Feb 71 (2): 212-9. Bonagura Vincent R, Du Zeying, Ashouri Elham, Luo Lihui, Hatam Lynda J, DeVoti James A, Rosenthal David W, Steinberg Bettie M, Abramson Allan L, Gjertson David W, Reed Elaine F, Rajalingam Ra |
|
Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.
Leukemia research 2010 Jan 34 (1): 55-8. Zhang Yan, Wang Bo, Ye Shihui, Liu Sheng, Liu Mengli, Shen Chunmei, Teng Yan, Qi J |
|
KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Dec 15 (23): 7330-4. Venstrom Jeffrey M, Zheng Junting, Noor Nabila, Danis Karen E, Yeh Alice W, Cheung Irene Y, Dupont Bo, O'Reilly Richard J, Cheung Nai-Kong V, Hsu Katharine |
|
Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.
Tissue antigens 2009 Jun 73 (6): 553-60. Middleton D, Diler A S, Meenagh A, Sleator C, Gourraud P |
|
Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2009 Apr 15 (4): 4. de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M, Minola E, Guido M, Boccagni P, De Feo TM, Torelli R, Cardillo M, Scalamogna M, Poli F |
|
Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.
Blood 2009 Jan 113 (3): 726-32. Cooley Sarah, Trachtenberg Elizabeth, Bergemann Tracy L, Saeteurn Koy, Klein John, Le Chap T, Marsh Steven G E, Guethlein Lisbeth A, Parham Peter, Miller Jeffrey S, Weisdorf Daniel |
- Page last reviewed:Mar 1, 2018
- Page last updated:May 9, 2019
- Content source: